Pawel G. Zalewski
1 Hospital Court, L1G 2B9
Oshawa, ON, Canada
Oshawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Long-Term Outcomes of Neoadjuvant Chemotherapy (NAC) Prior to Bladder-Sparing Trimodality Therapy (TMT) for Patients With Muscle-Invasive Bladder Cancer (MIBC).
Journal: Clinical genitourinary cancer
Published: March 30, 2026
Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 05, 2025
Patient-reported Outcomes in KEYNOTE-921: Pembrolizumab with Docetaxel and Prednisone for Patients with Metastatic Castration-resistant Prostate Cancer.
Journal: European urology oncology
Published: January 03, 2025
Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus.
Journal: Cancers
Published: August 08, 2024
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement.
Journal: Current oncology (Toronto, Ont.)
Published: February 12, 2024
Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate Cancer.
Journal: Journal of clinical medicine
Published: July 19, 2023
Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And Outcome.
Journal: Cancer management and research
Published: April 22, 2019
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 29, 2018
Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: February 01, 2018
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial.
Journal: The Lancet. Oncology
Published: October 11, 2016
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 14, 2016
Last Updated: 09/26/2026